Our History

Umecrine AB was founded in 2000 and is based on research performed at Umeå Neurosteroid Research Center, Umeå University, Sweden, showing that the negative effects of endogenous sex and stress hormones on the brain are possible to prevent. The negative effects are related to the influence of GABA steroids on the brain's main inhibiting system, the GABA system. The effect of Umecrine's patented and patent pending substances is to block the influence of GABA steroids on the GABAA receptor and thus preventing the GABA steroids from inducing negative CNS symptoms and disorders. The inventions represent unique and novel treatment principles with potential in several indication areas e.g. in the present case premenstrual disorders.




Torbjörn Bäckström

Chief Executive Officer

Phone +46 72 203 13 13



More contact details



Umeå Neurosteroid Research
Center (UNC)

Norrlands University Hospital

SE - 901 85 Umeå, Sweden


See on map



Umecrine AB

Registred office in Umeå

Reg no 556582-0684



© 2015 Umecrine